Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity

Obesity

Volumn 20, Issue 10, 2012, Pages 1984-1994

  Alvheim, Anita R ^a,b,c   Malde, Marian K ^a   Osei Hyiaman, Douglas ^b,d,e   Hong Lin, Yu ^b   Pawlosky, Robert J ^b   Madsen, Lise ^a,f   Kristiansen, Karsten ^f   Frøyland, Livar ^a   Hibbeln, Joseph R ^b  

^a INSTITUTE OF MARINE RESEARCH   (Norway)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c UNIVERSITY OF BERGEN   (Norway)

^d NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^e RIKEN   (Japan)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; MESSENGER RNA; OMEGA 3 FATTY ACID; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; ERYTHROCYTE LEVEL; FATTY ACID ANALYSIS; FEMALE; FOOD COMPOSITION; FOOD INTAKE; GENE EXPRESSION; LIPID DIET; LIVER LEVEL; LIVER PARENCHYMA; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PREVALENCE; WEANING; WHITE ADIPOSE TISSUE;

ANIMALS; ANIMALS, NEWBORN; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CANNABINOID RECEPTOR AGONISTS; CANNABINOID RECEPTOR MODULATORS; DIET, HIGH-FAT; ENDOCANNABINOIDS; LINOLEIC ACID; MALE; MICE; OBESITY; POLYUNSATURATED ALKAMIDES;

ANIMALIA; MUS;

EID: 84866735656     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.38     Document Type: Article

References (40)

1. Di Marzo V, Goparaju SK, Wang L et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001;410:822-825.
2. Osei-Hyiaman D, DePetrillo M, Pacher P et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 2005;115:1298-1305.
3. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 2006;27:73-100.
4. Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 2007;370:1706-1713.
5. Lands WE, Libelt B, Morris A et al. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta 1992;1180:147-162.
6. Wang J, Ueda N. Biology of endocannabinoid synthesis system. Prostaglandins Other Lipid Mediat 2009;89:112-119.
7. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr 2011;93:950-962.
8. Folch J, Lees M, Sloane stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
9. Zoerner AA, Gutzki FM, Batkai S et al. Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective. Biochim Biophys Acta 2011;1811:706-723.
10. Agren JJ, Julkunen A, Penttilä I. Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column. J Lipid Res 1992;33:1871-1876.
11. Salem N Jr, Reyzer M, Karanian J. Losses of arachidonic acid in rat liver after alcohol inhalation. Lipids 1996;31(Suppl):S153-S156.
12. Hansen JB, Petersen RK, Larsen BM et al. Activation of peroxisome proliferator-activated receptor gamma bypasses the function of the retinoblastoma protein in adipocyte differentiation. J Biol Chem 1999;274:2386-2393.
13. Madsen L, Petersen RK, Sørensen MB et al. Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process. Biochem J 2003;375:539-549.
14. Helmchen LA, Henderson RM. Changes in the distribution of body mass index of white US men, 1890-2000. Ann Hum Biol 2004;31:174-181.
15. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
16. Parikh NI, Pencina MJ, Wang TJ et al. Increasing trends in incidence of overweight and obesity over 5 decades. Am J Med 2007;120:242-250.
17. Batetta B, Griinari M, Carta G et al. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr 2009;139:1495-1501.
18. Matias I, Petrosino S, Racioppi A et al. Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets. Mol Cell Endocrinol 2008;286:S66-S78.
19. Piscitelli F, Carta G, Bisogno T et al. Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice. Nutr Metab (Lond) 2011;8:51.
20. Munakata M, Nishikawa M, Togashi N et al. The nutrient formula containing eicosapentaenoic acid and docosahexaenoic acid benefits the fatty acid status of patients receiving long-term enteral nutrition. Tohoku J Exp Med 2009;217:23-28.
21. Novak EM, Dyer RA, Innis SM. High dietary omega-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth. Brain Res 2008;1237:136-145.
22. Arbuckle LD, MacKinnon MJ, Innis SM. Formula 18:2(n-6) and 18:3(n-3) content and ratio influence long-chain polyunsaturated fatty acids in the developing piglet liver and central nervous system. J Nutr 1994;124:289-298.
23. Lands WE, Morris A, Libelt B. Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues. Lipids 1990;25:505-516.
24. Bourre JM, Piciotti M, Dumont O, Pascal G, Durand G. Dietary linoleic acid and polyunsaturated fatty acids in rat brain and other organs. Minimal requirements of linoleic acid. Lipids 1990;25:465-472.
25. Hill JO, Peters JC, Lin D et al. Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int J Obes Relat Metab Disord 1993;17:223-236.
26. D'Asti E, Long H, Tremblay-Mercier J et al. Maternal dietary fat determines metabolic profile and the magnitude of endocannabinoid inhibition of the stress response in neonatal rat offspring. Endocrinology 2010;151:1685-1694.
27. Osei-Hyiaman D, Depetrillo M, Harvey-White J et al. Cocaine-and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. Neuroendocrinology 2005;81:273-282.
28. Madsen L, Pedersen LM, Liaset B et al. cAMP-dependent signaling regulates the adipogenic effect of n-6 polyunsaturated fatty acids. J Biol Chem 2008;283:7196-7205.
29. Kim HJ, Miyazaki M, Ntambi JM. Dietary cholesterol opposes PUFA-mediated repression of the stearoyl-CoA desaturase-1 gene by SREBP-1 independent mechanism. J Lipid Res 2002;43:1750-1757.
30. Kim HJ, Takahashi M, Ezaki O. Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs. J Biol Chem 1999;274:25892-25898.
31. Gary-Bobo M, Elachouri G, Scatton B et al. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes. Mol Pharmacol 2006;69:471-478.
32. Perwitz N, Fasshauer M, Klein J. Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin. Horm Metab Res 2006;38:356-358.
33. D'Eon TM, Pierce KA, Roix JJ et al. The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids. Diabetes 2008;57:1262-1268.
34. Berger A, Crozier G, Bisogno T et al. Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci USA 2001;98:6402-6406.
35. Watanabe S, Doshi M, Hamazaki T. n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot Essent Fatty Acids 2003;69:51-59.
36. Artmann A, Petersen G, Hellgren LI et al. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 2008;1781:200-212.
37. Di Marzo V, Griinari M, Carta G et al. Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. Int Dairy J 2010;20:231-235.
38. Ailhaud G, Massiera F, Weill P et al. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res 2006;45:203-236.
39. Petrova S, Dimitrov P, Willett WC, Campos H. The global availability of n-3 fatty acids. Public Health Nutr 2011:1-8.
40. Caban AJ, Lee DJ, Fleming LE et al. Obesity in US workers: The National Health Interview Survey, 1986 to 2002. Am J Public Health 2005;95:1614-1622.